A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein
about
Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2Molecular mechanisms of prolactin and its receptorExpression in vitro of alternatively spliced variants of the messenger RNA for human apolipoprotein E receptor-2 identified in human tissues by ribonuclease protection assaysThe growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE)Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligaseRegulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice.An Ac-like transposable element family with transcriptionally active Y-linked copies in the white campion, Silene latifolia.Regulation of human growth hormone receptor expression by microRNAsA short receptor downregulates JAK/STAT signalling to control the Drosophila cellular immune response.Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.Growth hormone as a cytokine.Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosisThe GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Mutations in a dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias.The mechanism of effect of growth hormone on preadipocyte and adipocyte function.Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function.The role of prolactin in mammary carcinoma.Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling.Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant.Clinical and biochemical consequences of an intragenic growth hormone receptor (GHR) deletion in a large Chinese pedigree.Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.Altered expression of receptors for thyroid hormone and insulin-like growth factor-I during reconstitution after allogeneic hematopoietic stem cell transplantation.GHBP binds GHRGrowth hormone receptors in the atherinid Odontesthes bonariensis: characterization and expression profile after fasting-refeeding and growth hormone administration.Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.Impaired phosphorylation of JAK2-STAT5b signaling in fibroblasts from uremic children.
P2860
Q24293326-FCA80A2C-BFB4-4604-897F-4D4962C5538EQ27008904-1F3F29F5-0C44-4AAF-868B-3C353309E362Q28143176-C7F60272-CC00-4B5F-8C57-906A51C653B8Q28205859-100BD151-0DBF-4695-8586-8C7DFFB1219FQ28617041-0A3A3738-399C-44F7-8DE3-5CA21FC74A70Q30433639-1979E8F5-4E19-48D0-8E4E-68D7BAB990EFQ31015742-624568C2-CA58-4DE3-9390-BE570315DCCDQ33631926-080D8F5A-BB8A-4FEA-9C4B-B74299233B47Q33651034-0EA2162D-0B2B-4381-A6CE-813BA71CAB95Q33755171-18812DD8-8CF8-4680-A38A-E624A9180C35Q33767296-49EBDF70-6554-4AB0-B047-6FBD2AB94B3CQ34075980-9C410372-5EAF-437F-BBB4-0D9185706AC0Q34182483-D021AFBC-2E48-4BED-8206-3074A5C74957Q34389321-B40A2595-1FEC-4FB2-988B-647881294718Q34742732-19AC8007-1ADB-45C5-886D-C29454EA1474Q34922254-20367CC2-D06A-4D25-996F-E14D02EB1A20Q35067253-114ABF2E-A4B2-4226-8CE0-D44A19FE5ADAQ36397689-5D2EE7DA-6285-4917-8A3E-D3366526BF3BQ40342848-51B9CDE8-B224-4DF4-89DB-44A3FF221188Q42465169-5726887B-B39C-44DF-B561-EDEF257EA28DQ42478447-D5F78DB0-DFF8-45C8-9D3F-D51079D906C2Q43733296-5F041D8B-AC08-4CE4-9BB2-7BAC2A5E3765Q50293018-6F689C92-FB23-427A-A38E-80895B4D79C8Q51285711-42CB1138-0E23-4083-B0D5-D4C1EB990580Q51668688-31BD8CA1-69C4-4E55-BB01-B0111E2C6713Q52889975-A3200B7E-8916-456C-9199-83E008F2DACF
P2860
A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A short isoform of the human g ...... rge amounts of binding protein
@ast
A short isoform of the human g ...... rge amounts of binding protein
@en
A short isoform of the human g ...... rge amounts of binding protein
@nl
type
label
A short isoform of the human g ...... rge amounts of binding protein
@ast
A short isoform of the human g ...... rge amounts of binding protein
@en
A short isoform of the human g ...... rge amounts of binding protein
@nl
prefLabel
A short isoform of the human g ...... rge amounts of binding protein
@ast
A short isoform of the human g ...... rge amounts of binding protein
@en
A short isoform of the human g ...... rge amounts of binding protein
@nl
P2093
P356
P1476
A short isoform of the human g ...... rge amounts of binding protein
@en
P2093
Esposito N
Finidori J
Postel-Vinay MC
P304
P356
10.1210/MEND.11.3.9901
P407
P577
1997-03-01T00:00:00Z